_version_ 1811173216395198464
author Sobia Tabassum
author_facet Sobia Tabassum
author_sort Sobia Tabassum
collection DOAJ
first_indexed 2024-04-10T17:43:13Z
format Article
id doaj.art-68968f0fe231466bae1d48d4159d7bcc
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-10T17:43:13Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-68968f0fe231466bae1d48d4159d7bcc2023-02-03T07:04:31ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-02-011110.3389/fcell.2023.11027211102721Editorial: PROTACs: Targeted therapies for cancer treatmentSobia Tabassumhttps://www.frontiersin.org/articles/10.3389/fcell.2023.1102721/fullResearch Topicproteolysis-targeting chimeric molecule (PROTAC)cancer treatmentstate of artcutting edge technology
spellingShingle Sobia Tabassum
Editorial: PROTACs: Targeted therapies for cancer treatment
Frontiers in Cell and Developmental Biology
Research Topic
proteolysis-targeting chimeric molecule (PROTAC)
cancer treatment
state of art
cutting edge technology
title Editorial: PROTACs: Targeted therapies for cancer treatment
title_full Editorial: PROTACs: Targeted therapies for cancer treatment
title_fullStr Editorial: PROTACs: Targeted therapies for cancer treatment
title_full_unstemmed Editorial: PROTACs: Targeted therapies for cancer treatment
title_short Editorial: PROTACs: Targeted therapies for cancer treatment
title_sort editorial protacs targeted therapies for cancer treatment
topic Research Topic
proteolysis-targeting chimeric molecule (PROTAC)
cancer treatment
state of art
cutting edge technology
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1102721/full
work_keys_str_mv AT sobiatabassum editorialprotacstargetedtherapiesforcancertreatment